Gemphire Therapeutics gemphire.com


Public list: BIO 2016 (619) Pharma Startups (6570)

Gemphire Therapeutics is a clinical-stage biotech company. The company offers, Gemcabene, an oral once-daily drug candidate, that is being developed to treat the large unmet medical need of patients with high cardiovascular and pancreatitis risk who are unable to reach optimal LDL cholesterol or triglyceride levels with statin or other therapies.

Gemphire Therapeutics is a clinical-stage biotech company. The company offers, Gemcabene, an oral once-daily drug candidate, that is being developed to treat the large unmet medical need of patients with high cardiovascular and pancreatitis risk who ...Show all

Company (IPO / Went public)

Phone: 248-681-6538

Fax:

43334 Seven Mile Road
Suite 1000
Northville, 48167
Michigan, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Gemphire Therapeutics $18.3M Aug 5, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Gemphire Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Treatment of nash with gemcabene Jan 26, 2017 Dec 26, 2017 Patent
Treatment of nash with gemcabene Nov 16, 2017 Application
Treatment of patients with homozygous familial hypercholesterolemia on lipid lowering therapy Feb 28, 2017 Application
Treatment of mixed dyslipidemia Feb 03, 2017 Application
Processes and intermediates for preparing a,w -dicarboxylic acid-terminated dialkane ethers Nov 16, 2015 Application